EichorEICHOR
Study identifier: NCT03433274 Synced from ClinicalTrials.gov · August 02, 2026
● Active Not Recruiting

Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation

Condition: Mitral Regurgitation · Mitral Insufficiency · Mitral Valve Insufficiency  ·  Sponsor: Abbott Medical Devices

PhaseNA
Planned participants103
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Prospective, controlled, multicenter clinical investigation with four trial cohorts: Randomized, Non-repairable, Severe Mitral Annular Calcification (MAC) and Severe Mitral Annular Calcification Continued Access Plan (MAC CAP). Subjects in the Randomized cohort were randomized in a 1:1 ratio to the trial device or to the MitraClip system. Subjects in the Non-repairable, Severe MAC, and Severe MAC CAP cohorts were receive the trial device. The objective of the Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation (SUMMIT) was to evaluate the safety and effectiveness of the Tendyne Transcatheter Mitral Valve System for the treatment of patients with symptomatic, moderate-to-severe or severe mitral regurgitation or for patients with symptomatic mitral valve disease due to severe mitral annular calcification. This randomized controlled trial would provide the opportunity to evaluate the safety and clinical benefits of the Tendyne Transcatheter Mitral Valve System compared to the MitraClip System in patients with symptomatic, moderate-to-severe or severe mitral regurgitation, within approved MitraClip indications. In addition, the safety and effectiveness of the Tendyne Transcatheter Mitral Valve System would be evaluated in patients with severe mitral annular calcification who are at prohibitive risk for mitral valve surgery. Patients who were not suitable for mitral v…

This description comes directly from the study's public registry record.

Talk to the study team

No contact information is available for this study as per the public registry record.

Always discuss trial participation with your own doctor first.

Locations (78)

Baptist Medical Center PrincetonBirmingham, Alabama, United States
UAB University HospitalBirmingham, Alabama, United States
Banner-University Medical CenterPhoenix, Arizona, United States
Scottsdale Healthcare SheaScottsdale, Arizona, United States
Baptist Health Medical CenterLittle Rock, Arkansas, United States
Fresno Heart HospitalFresno, California, United States
University of Southern California University HospitalLos Angeles, California, United States
Cedars-Sinai Medical CenterLos Angeles, California, United States
Sutter Medical Center, SacramentoSacramento, California, United States
University of California - Davis Medical CenterSacramento, California, United States
San Diego Cardiac CenterSan Diego, California, United States
University of California at San FranciscoSan Francisco, California, United States

+ 66 more locations — full list on the registry record.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →